Arcus Biosciences Inc (RCUS)
Healthcare
Biotechnology
28.20 $
-0.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -482 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -25 | -43 | -73 | 111 | -256 | 438 | -306 | -170 | -482 | |
| 1.3 | 2.6 | 3.7 | 3.6 | 4.2 | 3.8 | 14 | 8.0 | 10 | 10 | |
| 0.1 | 0.5 | 3.9 | 9.0 | 22 | 55 | 65 | 73 | 76 | 60 | |
| 0.1 | 0.8 | 3.4 | 10 | 22 | 55 | 76 | – | – | – | |
| 3.6 | 25 | 1.3 | 0.1 | 208 | -376 | 623 | -71 | 22 | -194 | |
| 4.1 | 5.5 | 3.7 | 1.9 | 3.1 | 26 | 6.0 | 24 | 6.0 | 2.0 | |
| -39 | -49 | -113 | 59 | -434 | -3.9 | -413 | 194 | -84 | 66 | |
| – | – | – | – | – | 5.0 | – | – | – | – | |
| 70 | 108 | 125 | -0.1 | -0.1 | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | – | – | 0.0 | 0.0 | 47 | 49 | |
| 70 | 107 | 129 | 1.1 | 439 | 237 | 33 | 33 | 277 | 488 | |
| 18 | 33 | -27 | -13 | 115 | -23 | 58 | -79 | 23 | 72 | |
| -17 | -31 | -47 | -75 | 108 | -282 | 432 | -330 | -176 | -484 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.